RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Arch Biopartners Stock

Arch Biopartners ROE 2024

Arch Biopartners ROE

0.6

Ticker

ARCH.V

ISIN

CA03938C1041

In 2024, Arch Biopartners's return on equity (ROE) was 0.6, a 91.73% increase from the 0.31 ROE in the previous year.

Arch Biopartners Aktienanalyse

What does Arch Biopartners do?

Arch Biopartners ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Arch Biopartners's Return on Equity (ROE)

Arch Biopartners's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Arch Biopartners's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Arch Biopartners's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Arch Biopartners’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Arch Biopartners stock

What is the ROE (Return on Equity) of Arch Biopartners this year?

The ROE of Arch Biopartners this year is 0.6 undefined.

How has the Return on Equity (ROE) of Arch Biopartners developed compared to the previous year?

The ROE of Arch Biopartners has increased by 91.73% increased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Arch Biopartners?

A high ROE indicates that Arch Biopartners generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Arch Biopartners?

A low ROE can indicate that Arch Biopartners is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Arch Biopartners affect the company?

A change in ROE (Return on Equity) of Arch Biopartners can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Arch Biopartners?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Arch Biopartners?

Some factors that can influence Arch Biopartners's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Arch Biopartners pay?

Over the past 12 months, Arch Biopartners paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Arch Biopartners is expected to pay a dividend of 0 CAD.

What is the dividend yield of Arch Biopartners?

The current dividend yield of Arch Biopartners is .

When does Arch Biopartners pay dividends?

Arch Biopartners pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Arch Biopartners?

Arch Biopartners paid dividends every year for the past 0 years.

What is the dividend of Arch Biopartners?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Arch Biopartners located?

Arch Biopartners is assigned to the 'Health' sector.

Wann musste ich die Aktien von Arch Biopartners kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Arch Biopartners from 11/9/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 11/9/2024.

When did Arch Biopartners pay the last dividend?

The last dividend was paid out on 11/9/2024.

What was the dividend of Arch Biopartners in the year 2023?

In the year 2023, Arch Biopartners distributed 0 CAD as dividends.

In which currency does Arch Biopartners pay out the dividend?

The dividends of Arch Biopartners are distributed in CAD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Arch Biopartners

Our stock analysis for Arch Biopartners Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Arch Biopartners Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.